Prediction of coronary artery disease risk based on multiple longitudinal biomarkers

Lili Yang1, Menggang Yu2, Sujuan Gao3

  • 1Eli Lilly and Company, Indianapolis, IN, 46285, U.S.A.

Statistics in Medicine
|October 7, 2015
PubMed

Insights

Analyzing blood pressure trajectories improves cardiovascular disease risk prediction. Longitudinal blood pressure (BP) data offers better insights than single measurements for predicting coronary artery disease events.

Area of Science:

  • Cardiovascular Disease Research
  • Biostatistics
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) risk prediction is a critical area of research.
  • High blood pressure (BP) is a major CVD risk factor.
  • Current models use single BP measurements, not reflecting longitudinal BP changes.

Purpose of the Study:

  • To develop and evaluate joint models for predicting coronary artery disease (CAD) events.
  • To assess the predictive performance of models incorporating longitudinal BP data.
  • To compare joint models with traditional risk prediction methods.

Main Methods:

  • Utilized a primary care cohort with up to 20 years of follow-up.
  • Employed joint modeling to analyze time-to-event data (CAD) and longitudinal BP measurements (systolic and diastolic).
  • Applied novel prediction metrics and simulations to evaluate model performance.

Main Results:

  • Longitudinal BP trajectories demonstrated significant predictive power for CVD events.
  • Joint models incorporating BP trajectories showed improved predictive performance compared to traditional models.
  • Simulations confirmed the enhanced predictive capabilities of the proposed joint models.

Conclusions:

  • Longitudinal analysis of blood pressure provides superior cardiovascular risk prediction.
  • Joint modeling offers a more accurate approach to assessing CVD risk by integrating time-dependent BP data.
  • These findings can inform clinical guidelines for more effective CVD prevention strategies.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
857
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
837
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
983
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
767
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
764